Analystreport

Matinas Biopharma Holdings, Inc. (NASDAQ: MTNB) had its "buy" rating re-affirmed by analysts at Aegis.

Matinas Biopharma Holdings, Inc.  (MTNB) 
NASDAQ:AMEX Investor Relations: ir.matinasbiopharma.com